IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GIACOMINI, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.715
EU - Europa 2.420
AS - Asia 2.254
SA - Sud America 450
AF - Africa 54
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.908
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.637
SG - Singapore 786
PL - Polonia 746
CN - Cina 686
IT - Italia 408
BR - Brasile 370
UA - Ucraina 309
DE - Germania 286
HK - Hong Kong 231
FI - Finlandia 187
VN - Vietnam 183
FR - Francia 96
GB - Regno Unito 90
TR - Turchia 79
BD - Bangladesh 78
RU - Federazione Russa 71
IE - Irlanda 67
IN - India 62
CA - Canada 38
SE - Svezia 36
AR - Argentina 30
ID - Indonesia 25
JP - Giappone 24
IQ - Iraq 23
NL - Olanda 23
CZ - Repubblica Ceca 22
MX - Messico 22
BE - Belgio 19
ZA - Sudafrica 18
ES - Italia 17
EC - Ecuador 14
AT - Austria 10
PK - Pakistan 9
SA - Arabia Saudita 9
UZ - Uzbekistan 8
VE - Venezuela 8
CH - Svizzera 7
MA - Marocco 7
NG - Nigeria 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
EU - Europa 6
PE - Perù 6
UY - Uruguay 6
AU - Australia 5
PY - Paraguay 5
TH - Thailandia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CO - Colombia 4
JM - Giamaica 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
PH - Filippine 4
CR - Costa Rica 3
EG - Egitto 3
GR - Grecia 3
HR - Croazia 3
JO - Giordania 3
KR - Corea 3
KZ - Kazakistan 3
LK - Sri Lanka 3
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GD - Grenada 2
GE - Georgia 2
IL - Israele 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
ZM - Zambia 2
AO - Angola 1
BO - Bolivia 1
DK - Danimarca 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MG - Madagascar 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
NR - Nauru 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.904
Salva come PNG Salva come JPEG
Città #
Warsaw 741
Fairfield 542
Ashburn 482
Singapore 455
Woodbridge 334
Hong Kong 231
Jacksonville 221
Houston 219
Cambridge 214
San Jose 197
Seattle 189
The Dalles 188
Wilmington 183
Chandler 170
Brescia 169
Beijing 157
Ann Arbor 145
Helsinki 137
Princeton 116
New York 110
Los Angeles 96
Munich 78
Dearborn 76
Dublin 63
Lauterbourg 62
Istanbul 58
Ho Chi Minh City 53
Nanjing 51
Council Bluffs 48
São Paulo 43
Chicago 37
Hanoi 37
Dong Ket 35
Des Moines 34
Redondo Beach 34
Orem 33
Dallas 32
San Francisco 32
Santa Clara 31
Shanghai 29
Buffalo 27
Milan 26
San Diego 26
Nanchang 25
Moscow 22
Shenyang 21
Tokyo 21
London 19
Turku 19
Brussels 18
Jakarta 18
Jinan 18
Brno 17
Phoenix 17
Changsha 16
Denver 16
Boston 14
Chennai 14
Hebei 14
Guangzhou 13
Montreal 13
Rio de Janeiro 13
Verona 13
Amsterdam 12
Frankfurt am Main 12
Tianjin 12
Toronto 12
Johannesburg 11
Stockholm 11
Atlanta 10
Baghdad 10
Belo Horizonte 10
Dhaka 10
Jiaxing 10
Kocaeli 10
Lappeenranta 10
Boardman 9
Brooklyn 9
Charlotte 9
Da Nang 8
Falkenstein 8
Hefei 8
Lanzhou 8
Nuremberg 8
Tampa 8
Tashkent 8
Washington 8
Haikou 7
Hangzhou 7
Ningbo 7
Porto Alegre 7
Turin 7
Abuja 6
Campinas 6
Curitiba 6
Kunming 6
Lancaster 6
Mexico City 6
Parma 6
Rome 6
Totale 6.896
Salva come PNG Salva come JPEG
Nome #
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 377
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 343
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 304
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 302
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 287
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. 247
Long pentraxin-3 follows and modulates bladder cancer progression 221
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 206
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 202
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 202
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells 197
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 190
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 189
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 187
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation. 182
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 181
Myeloablative doses of yttrium-90-ibritumomab tiuxetan and the risk of secondary myelodysplasia/acute myelogenous leukemia 170
Circulating microRNAs and Their Role in Multiple Myeloma 169
Long pentraxin 3: A novel multifaceted player in cancer 167
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 163
Combining vascular disruption activity of TRAIL-expressing CD34+ cells with antiangiogenic activity of sorafenib improves regression of tumor growth 154
Future applications of FGF/FGFR inhibitors in cancer 153
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy 149
Human CD34 + cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature 147
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 147
The autocrine fgf/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach 143
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity 142
A computational approach to compare microvessel distributions in tumors following antiangiogenic treatments 140
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 139
FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer 139
Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease 136
Uptake Profiles of Human Serum Exosomes by Murine and Human Tumor Cells through Combined Use of Colloidal Nanoplasmonics and Flow Cytofluorimetric Analysis 135
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 133
(3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies 132
FGF Trapping Inhibits Multiple Myeloma Growth through c-Myc Degradation-Induced Mitochondrial Oxidative Stress 131
sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib 131
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells 130
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts 128
Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer 123
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 121
Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 120
Stromal expression of long Pentraxin-3 impairs tumor growth and metastasis 117
Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors 113
Potent in vivo anti-tumor activity of extracellular vesicles isolated from genetically engineered primary mesenchymal stromal cells expressing the trans-membrane TNF-Related Apoptosis-Inducing Ligand (TRAIL) 111
Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model 111
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma 111
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 108
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 107
Iron supplementation enhances RSL3-induced ferroptosis to treat naïve and prevent castration-resistant prostate cancer 107
Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer 106
Inhibition of the FGF/FGFR System Induces Apoptosis in Lung Cancer Cells via c-Myc Downregulation and Oxidative Stress 106
PTX3 Modulates Neovascularization and Immune Inflammatory Infiltrate in a Murine Model of Fibrosarcoma 105
The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer 101
β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism 97
The FGF/FGFR System in the Physiopathology of the Prostate Gland 96
FGF-trapping hampers cancer stem-like cells in uveal melanoma 94
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors 91
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma 90
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity 89
Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature 82
Post-transplant evaluation of bone marrow hematopoietic function in patients receiving high-dose Yttrium-90-Ibritumomab Tiuxetan (Zevalin) with autograft 77
The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination 76
Targeting TRAIL Receptors with Genetically-Engineered CD34+ Hematopoietic Stem Cells 73
Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist 70
The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients 70
Proteasome inhibitors as anticancer agents 66
Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas 65
The histone deacetylase inhibitor ITF2357 (Givinostat) promotes Burkitt’s lymphoma cell line death modulating micro-RNA and Tissue Transglutaminase 2 expression 64
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 61
Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma 61
An ureido-substituted benzenesulfonamide carbonic anhydrase inhibitor exerts a potent antitumor effect in vitro and in vivo 57
Monoclonal antibodies for targeted treatment of lymphoproliferative neoplasias 45
Totale 10.086
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202192 0 0 0 0 0 0 0 0 0 0 0 92
2021/2022593 38 79 29 21 20 40 38 42 16 74 46 150
2022/2023497 80 15 29 29 43 120 6 51 68 1 37 18
2023/2024615 42 13 96 27 20 101 22 26 125 24 17 102
2024/20251.351 21 23 14 198 131 140 118 81 146 88 229 162
2025/20263.069 303 369 202 421 344 230 458 120 160 262 140 60
Totale 10.086